FEP policy 5.99.027, effective January 2026

Does Blue Cross Blue Shield Cover Wegovy?

There is no single Blue Cross answer, and anyone who gives you one is guessing. "Blue Cross Blue Shield" is 33 independent companies plus one national program for federal employees. They set their own formularies, and they do not agree with each other about Wegovy.

What we can do is give you the one policy that is national — the Federal Employee Program's 5.99.027, effective January 1, 2026, which we archived on July 25 — and show you how to find your own. Two of its rules catch people out and appear on no other insurer's page we have read.

Key takeaways
  • Your answer depends on which Blue you have: Anthem, a state Blue, or FEP. Start by identifying that.
  • FEP requires participation in a comprehensive weight-management program — and names Teladoc as an example.
  • No dual therapy. You cannot be on two prior-authorization weight-loss drugs at once, which quietly complicates a switch.
  • Renewal needs 5% of baseline lost or maintained, plus still being enrolled in the program.
  • Your Blue says no? Compare cash-pay prices before paying retail. How we make money.

Does Blue Cross Blue Shield cover Wegovy?

On the Federal Employee Program, yes — with prior authorization, administered through CVS Caremark. On the 33 independent Blues, it depends entirely on which one you have and what your employer elected. The brand on your card tells you almost nothing on its own.

There is a structural reason Wegovy tends to fare better than Zepbound across the Blues: CVS Caremark, which administers pharmacy benefits for FEP and for many Blue plans, made Wegovy its preferred GLP-1. The same dynamic drives Aetna's answer, since Aetna is also CVS-owned. If you are comparing the two drugs, see our Blue Cross and Zepbound guide.

Anthem, a state Blue, or FEP: three different answers

Before reading any criteria, work out which of three situations you are in, because the criteria below only govern the third.

Which Blue you have, and what decides your coverage
If your card saysWhat governs
Anthem (14 states)Anthem's own formulary and any employer rider. The largest single Blue, and it publishes its own criteria.
A state Blue — Blue Cross of Massachusetts, BCBSNC, BCBSND and so onThat company's own drug list. Several changed their GLP-1 rules for 2026 independently of each other.
Blue Cross Blue Shield Service Benefit Plan / FEP (Standard, Basic, Blue Focus)National policy 5.99.027, prior authorization through CVS Caremark. This is the one document that applies the same way everywhere.

Policy 5.99.027: what federal employees must document

FEP treats weight-loss medications as medically necessary only when the prior-approval conditions are met. For adults the BMI route splits in an unusual way.

At BMI 30 or higher, nothing further is needed. At BMI 27 or higher you need either established cardiovascular disease — the policy spells this out as congenital heart disease, cerebrovascular disease, peripheral artery disease, coronary heart disease, acute coronary syndrome, myocardial infarction, unstable angina, coronary or other arterial revascularization, or prior percutaneous coronary intervention or bypass surgery — or at least one weight-related comorbidity such as type 2 diabetes, dyslipidemia or hypertension. Patients aged 12 to 17 qualify at a BMI in the 95th percentile or above.

The program rule, and the one company FEP names

Every insurer we have documented requires some form of weight-management program. FEP is the only one that names a vendor in the policy text.

FEP policy 5.99.027 requiring participation in a comprehensive weight management program such as Teladoc
"Patient has participated in a comprehensive weight management program (e.g., Teladoc or another weight loss program)" (highlighted).FEP pharmacy policy 5.99.027, effective 2026-01-01, original policy date 2022-09-09. Captured July 25, 2026.

Two things follow. First, unlike Aetna's six months or Cigna's three, FEP states no minimum duration — the requirement is participation, not a waiting period. Second, naming Teladoc gives you something concrete to ask about, since FEP members often already have access to it as a plan benefit. Ask whether your enrolment can be evidenced for the prior authorization.

No dual therapy: the rule that quietly blocks a switch

This one appears in no other policy we have archived, and it changes how a medication switch has to be sequenced.

FEP policy 5.99.027 stating no dual therapy with another prior authorization weight loss medication
"NO dual therapy with another Prior Authorization (PA) medication for weight loss" — a condition of both initial approval and renewal (highlighted).Same document, prior-approval requirements. Captured July 25, 2026.

If you hold an active authorization for Zepbound, Saxenda or Qsymia, a Wegovy request is not simply an addition — the existing one has to be resolved. Raise the sequencing with your prescriber before the request goes in, because a denial on this ground reads like a clinical rejection when it is really a scheduling problem.

Renewal turns on 5%, and on staying enrolled

FEP renewal criteria requiring five percent baseline weight loss or maintenance of that loss
Renewal for adults: at least 5% of baseline lost, or the initial 5% maintained (highlighted).Same document, prior-approval renewal requirements. Captured July 25, 2026.

The renewal list repeats the program requirement and the dual-therapy bar. That second appearance matters: this is not a box you tick once at the start. You must still be participating in a weight-management program when the renewal is submitted, and adolescents aged 12 to 17 are judged on maintaining clinically significant weight loss rather than a fixed percentage.

The practical move is the same one every insurer rewards: a dated weight in the chart at every visit from the first fill. A home scale is not documentation.

Why did Blue Cross deny my Wegovy?

Three causes, in rough order of frequency: your plan does not include a weight-loss benefit at all, the program-participation evidence was missing, or you had an active authorization for another weight-loss drug.

Get the reason in writing before you do anything. A benefit exclusion is not appealable in any useful sense — the realistic routes are a formulary exception, a different covered indication if one genuinely applies, or paying cash. A criteria denial is fixable, and the fix is usually one specific document rather than a better argument.

Finding your plan's actual drug list

  1. Read the top-left of your card. "Anthem", a state name, or "Service Benefit Plan" tells you which of the three situations above you are in.
  2. FEP members: the criteria on this page apply, and prior authorization runs through CVS Caremark rather than your Blue directly.
  3. Everyone else: search your own Blue's site for its 2026 formulary and for "weight loss" and "anti-obesity" in your plan documents. A national article cannot answer this for you, and any page that claims to is guessing.

If the drug list comes back without Wegovy on it, that is your answer and no prior authorization changes it. Price the cash route rather than spending weeks on a request that cannot succeed. Compare verified programs. How we make money.

FAQ

Does the federal employee plan cover Wegovy?

Yes, with prior authorization under policy 5.99.027, on Standard, Basic and Blue Focus, administered through CVS Caremark. You need the BMI criteria, program participation, and no competing weight-loss authorization.

Does Anthem Blue Cross cover Wegovy?

Anthem sets its own formulary across its 14 states and layers employer riders on top, so this is a plan-level question rather than a brand-level one. Check Anthem's current drug list and your own plan documents.

How long is the weight-management program requirement?

FEP does not state a minimum duration — it requires participation rather than a waiting period, and requires it again at renewal. That is a lower bar than Aetna's six months or Cigna's three.

Can I switch from Zepbound to Wegovy on FEP?

Not while both authorizations are live. The policy bars dual therapy with another prior-authorization weight-loss medication, so the switch has to be sequenced rather than overlapped.

Why do different Blue Cross plans give different answers?

Because they are different companies. Thirty-three independent licensees set their own formularies, and several changed their GLP-1 rules independently for 2026.

Sources and update history

Primary document, archived July 25, 2026: FEP pharmacy policy 5.99.027, Weight Loss Medications, effective January 1, 2026, original policy date September 9, 2022. State Blue formularies are published separately by each licensee and are not covered by this document. Companion pages: Blue Cross and Zepbound, Aetna and Wegovy, Cigna and Wegovy.

This is coverage information, not benefits or medical advice. Whether Wegovy is appropriate for you is a decision for you and your clinician; what your plan pays is decided by your plan documents, which vary by licensee.